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Abstract 
Review on MIR200A, with data on RNA, and where 
it is implicated. 
Keywords: MIR200A 
Identity 
HGNC (Hugo): MIR200A 
Location: 1p36.33 
Note 
MicroRNA 200a belongs to microRNA 200 family. 
MicroRNA 200 family consists of five microRNAs, 
microRNA 200b, microRNA 200a, microRNA 429, 
microRNA 200c and microRNA 141. MicroRNA 
200b, microRNA 200a and microRNA 429 were 
transcribed as a single ploycistronic transcript from 
chromosome 1. And microRNA 200 family were 
demonstrated important roles in EMT (epithelial-
mesenchymal transition) progress. 
DNA/RNA 
Description 
microRNA 200a located in chromosome 1 and 
microRNA 200a was transcribed with microRNA 
200b and microRNA 429 as a ploycistronic 
transcript. The putative transcription start site locates 
about 4987 bp upstream of the precursor of 
microRNA 200a. 
Transcription 
MiR-200a precursor: 5'-
CCGGGCCCCUGUGAGCAUCUUACCGGACA
GUGCUGGAUUUCCCAGCUUGACUCUAACA
CUGUCUGGUAACGAUGUUCAAAGGUGACC
CGC-3' 
Mature miR-200a: 5'-
UAACACUGUCUGGUAACGAUGU-3' 
Pseudogene 
No pseudogene was found. 
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Protein 
Note 
microRNAs are not translated into proteins. 
Implicated in 
Tumor cell proliferation 
MiR-200a showed its roles in regulation of tumor 
cell proliferation.  
In human endometrial adenocarcinoma cell line 
HEC-1B, repression of miR-200a could increase the 
tumor suppressor gene PTEN and thus inhibit cell 
proliferation and promote cell apoptosis, which 
showed the oncogenic role of miR-200a (Li, He et 
al. 2014). However, studies in breast cancer also 
demonstrated that miR-200a could attenuate cell 
proliferation by targeting Mitochondrial 
Transcription Factor A (Yao, Zhou et al. 2014). As 
well, miR-200a was also proved to impair glioma 
cell growth by targeting SIM2-s (Su, He et al. 2014). 
Tumor cells invasion and cancer 
metastasis 
As a member of miR-200 family, miR-200a showed 
its regulation roles in cancer cells invasion and 
migration.  
By targeting SIM-2, miR-200a could inhibit glioma 
cell migration and invasion (Su, He et al. 2014). In 
CD133/1+ ovarian cancer stem cells, miR-200a 
could inhibit cell migration and invasion by 
repressing expression of Zeb2 (which is a repressor 
of E-cadherin) (Wu, Guo et al. 2011). However, in 
human breast cancer cells, it was found that miR-
200a could target YAP1 thus induce anoikis 
resistance and metastasis (Yu, Hu et al. 2013). 
Repression of epithelial-
mesenchymal transition (EMT) 
Roles of miR-200 family in EMT regulation were 
intensively studied. As miR-200a, it was reported  
that miR-200a could regulate EMT by targeting 
SIRT1 and mammary epithelial cells (Eades, Yao et 
al. 2011). In hepatic oval cells, downregulation of 
miR-200a induces EMT phenotypes and CSC-like 
signatures by directly targeting beta-catenin (Liu, 
Ruan et al. 2013). 
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